成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Ruxolitinib intermediate

Ruxolitinib intermediate Struktur
1236033-04-7
CAS-Nr.
1236033-04-7
Englisch Name:
Ruxolitinib intermediate
Synonyma:
Ruxolitinib intermediate;Ruxolitinib Impurity 25 (+)-Dibenzoyltartaric Acid Salt;(3R)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]prop;(R)-3-cyclopenyl-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-l-yl)propanenitrile(2R, 3R)-2,3-bis(benzoyloxy)succinate;(3R)-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile (2S,3S)-2,3-bis(benzoyloxy)succinic acid salt;(2S,3S)-2,3-bis(benzoyloxy)butanedioic acid (3R)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile
CBNumber:
CB03161650
Summenformel:
C41H46N6O9Si
Molgewicht:
794.94
MOL-Datei:
1236033-04-7.mol

Ruxolitinib intermediate Eigenschaften

Sicherheit

Ruxolitinib intermediate Chemische Eigenschaften,Einsatz,Produktion Methoden

Ruxolitinib intermediate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Ruxolitinib intermediate Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 10)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Suzhou ARTK Medchem Co., Ltd.
+86-512-68323658 +86-18168183658
sales1@artkmedchem.com China 39004 58
Elucigen bio 13501719342
wayne.zheng@elucigenbio.com China 5089 58
Shanghai Hope Chem Co., Ltd., +21-18501659228 18501659228
info@hope-chem.com China 482 55
Jinan elephant international trading co., LTD
13006575422@163.com China 6355 58
Jiangsu Nanchuang Chemical and Life Health Research Institute Co., Ltd. 15720605021
zhang_lei@jsnchem.com China 1611 58
JinOu Biomedical (Nanjing) Co., Ltd. 13000000000
jinoupharma@163.com China 11721 58
Changzhou Bojia Biomedical Technology Co., Ltd. 2122619822
czbjpharma@126.com China 18478 58
PharmaBlock Sciences (Nanjing), Inc. 4000255188 4000255188
sales@pharmablock.com China 7268 58
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd. 025-66113011 18112977050
cb5@aikonchem.com China 10528 58
Shanghai Youna Biopharmaceutical Co., Ltd 18164002430
511710754@qq.com China 228 58

  • Ruxolitinib intermediate
  • (3R)-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile (2S,3S)-2,3-bis(benzoyloxy)succinic acid salt
  • (R)-3-cyclopenyl-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-l-yl)propanenitrile(2R, 3R)-2,3-bis(benzoyloxy)succinate
  • (3R)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]prop
  • (2S,3S)-2,3-bis(benzoyloxy)butanedioic acid (3R)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile
  • Ruxolitinib Impurity 25 (+)-Dibenzoyltartaric Acid Salt
  • 1236033-04-7
  • C18H14O8C23H32N6OSi
Copyright 2019 ? ChemicalBook. All rights reserved